Manuka Honey Inhibits Human Breast Cancer Progression in Preclinical Models - PubMed

Manuka honey (MH) exhibits potential antitumor activity in preclinical models of a number of human cancers. Treatment in vitro with MH at concentrations ranging from 0.3 to 5.0% (<i>w</i>/<i>v</i>) led to significant dose-dependent inhibition of proliferation of human breast cancer MCF-7 cells, but …